Loading...
Impact of sacubitril–valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO‐SAS study design
AIMS: Sleep‐disordered breathing (SDB) is a highly prevalent co‐morbidity in patients with chronic heart failure (CHF) and can play a detrimental role in the pathophysiology course of CHF. However, the best way to manage SDB in CHF remains a matter of debate. Sacubitril–valsartan has been included i...
Na minha lista:
| Udgivet i: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933955/ https://ncbi.nlm.nih.gov/pubmed/29469206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12270 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|